International Clinical Trial: Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820046) titled 'Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Tanta University

Condition: Ulcerative Colitis (UC)

Intervention: Drug: Nitazoxanide (NTZ)

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: January 1, 2027

Target Sample Size: 44

To know more, visit https://clinicaltrials.gov/study/NCT07820046

Disclaimer: Curated by HT Syndication....